Symmetrix Biotech Private Limited
About Symmetrix Biotech Private Limited
Data last updated:
Symmetrix Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Enem Nostrum Remedies Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 24 January 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2007PTC167239. Its GSTIN is 04AAKCS5535M1ZZ (Chandigarh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹65 Cr and a paid-up capital of ₹49.51 Cr. It is led by directors including Yatindra Prashar and Kaushik Krishnakant Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No.101 Gayatri Commercial Complex Marol, Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.54 Lakh, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹71.75 Lakh and EBITDA of -₹28.47 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 74% over three years and 58% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.45 Cr and satisfied charges of ₹12 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Symmetrix Biotech Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No.101 Gayatri Commercial Complex Marol, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Symmetrix Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Symmetrix Biotech is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Symmetrix Biotech Private Limited, buy the company report.
Financials of Symmetrix Biotech Private Limited
FY 2025 filings availableSymmetrix Biotech Private Limited reported revenue of ₹5.54 Lakh (down 89% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 58% over five years, including a 89% fall in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹28.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹71.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symmetrix Biotech Private Limited, buy the company report.
Board of directors of Symmetrix Biotech Private Limited
Symmetrix Biotech has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yatindra Prashar | Director | 16 Jun 2009 | 17 Years 4 Months | Current |
| Kaushik Krishnakant Vyas | Director | 03 Aug 2021 | 5 Years 2 Months | Current |
| Rama Ravikiran Marathe | Director | 08 Mar 2013 | 13 Years 7 Months | Current |
| Anilkumar Shridhar Mulye Also directs: Enem Nostrum Remedies Private Limited, Nexgen Healthcare Private Limited, Nli Healthcare (India) Private Limited and 5 more | Director | 11 Sep 2024 | 2 Years 1 Months | Current |
| Shraddha Vinayak Dhamankar Also directs: Thurs Organics Private Limited, Enem Nostrum Remedies Private Limited, Nexgen Healthcare Private Limited and 5 more | Director | 24 Jan 2007 | 19 Years 8 Months | Current |
Auditor
Symmetrix Biotech Private Limited is audited by Gokhale & Sathe for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gokhale & Sathe | FY 2022 | 103264W |
Shareholding
The shareholding of Symmetrix Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Symmetrix Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2014 | 10486876 | Biotechnology Industry Research Assistance Council | ₹5.45 Cr | Open | |
| 22 Jul 2013 | 10448611 | Technology Development Board | ₹12 Cr | Satisfied |
To see the full charge records of Symmetrix Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Symmetrix Biotech Private Limited has 6 court cases on record: 2 filed by Symmetrix Biotech, 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 0 |
Cases on record (3 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Arbitration matter | Filed against the company by Council of Scientific and Industrial Research | Disposed |
| Bombay High Court | Court case (CARAP) | Filed by the company against Fabtech Technologies International Limited | Disposed |
| Bombay High Court | Arbitration matter | Filed against the company by Fabtec Technologies International Limited | Disposed |
To see the full case history of Symmetrix Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Symmetrix Biotech Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 7 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| GRP Security Private Limited | |||
| Gokhale & Sathe |
To see the full MSME payment records of Symmetrix Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Symmetrix Biotech Private Limited has a workforce of 2 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Symmetrix Biotech has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAKCS5535M1ZZ | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Symmetrix Biotech Private Limited, buy the company report.
Recent activity
Symmetrix Biotech Private Limited has 14 board changes on record since 2007: 6 appointments and 8 cessations. The latest: Anilkumar Shridhar Mulye ceased to be Additional Director on 29 Sep 2024.
8 earlier events are in the company report.
Frequently asked questions
Symmetrix Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 24 January 2007 (19+ years old) and is registered under CIN U24239MH2007PTC167239.
Symmetrix Biotech has 5 current directors:
- Yatindra Prashar - Director
- Kaushik Krishnakant Vyas - Director
- Rama Ravikiran Marathe - Director
- Anilkumar Shridhar Mulye - Director
- Shraddha Vinayak Dhamankar - Director
The latest financial statements of Symmetrix Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Symmetrix Biotech is 04AAKCS5535M1ZZ, registered in Chandigarh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Symmetrix Biotech is U24239MH2007PTC167239. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symmetrix Biotech has 6 court cases on record: 2 filed by the company and 4 filed against it.
Symmetrix Biotech was incorporated on 24 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Anilkumar Shridhar Mulye ceased to be Additional Director on 29 Sep 2024. Jayant Hari Ranade ceased to be Director on 15 Sep 2024. Anilkumar Shridhar Mulye was appointed as Director on 11 Sep 2024. Symmetrix Biotech has 14 board changes on record in total.
Symmetrix Biotech has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 7 overdue payments to 2 micro and small suppliers. The latest return was filed on 02 May 2024.
The registered office of Symmetrix Biotech is at Unit No.101 Gayatri Commercial Complex Marol, Mumbai, Maharashtra, India – 400059.
Symmetrix Biotech operates in the pharma industry, in the pharma contract r and d segment.